151 related articles for article (PubMed ID: 35894811)
1. The occurrence and associated risk factors of brain metastases in well differentiated grade 1 and 2 bronchial neuroendocrine tumours: A single centre retrospective analysis of 280 patients.
Spurgeon L; Jones J; Lewis A; Rammohan K; Shaheen F; Weaver J; Papaxoinis G; Mansoor W
J Neuroendocrinol; 2022 Jul; 34(7):e13180. PubMed ID: 35894811
[TBL] [Abstract][Full Text] [Related]
2. [Pulmonary neuroendocrine tumors. The spectrum of histologic subtypes and current concept on diagnosis and treatment].
Langfort R; Rudziński P; Burakowska B
Pneumonol Alergol Pol; 2010; 78(1):33-46. PubMed ID: 20162517
[TBL] [Abstract][Full Text] [Related]
3. Molecular markers help characterize neuroendocrine lung tumors.
Rusch VW; Klimstra DS; Venkatraman ES
Ann Thorac Surg; 1996 Sep; 62(3):798-809; discussion 809-10. PubMed ID: 8784011
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis of atypical carcinoid can be made on biopsies > 4 mm
Reuling EMBP; Naves DD; Daniels JMA; Dickhoff C; Kortman PC; Broeckaert MAMB; Plaisier PW; Thunnissen E; Radonic T
Virchows Arch; 2022 Mar; 480(3):587-593. PubMed ID: 35089404
[TBL] [Abstract][Full Text] [Related]
5. Advances in the Diagnosis and Management of Well-Differentiated and Intermediate-Differentiated Neuroendocrine Tumors of the Lung.
Wolin EM
Chest; 2017 May; 151(5):1141-1146. PubMed ID: 27373769
[TBL] [Abstract][Full Text] [Related]
6. Automated quantification of Ki-67 proliferative index of excised neuroendocrine tumors of the lung.
Liu SZ; Staats PN; Goicochea L; Alexiev BA; Shah N; Dixon R; Burke AP
Diagn Pathol; 2014 Oct; 9():174. PubMed ID: 25318848
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis and management of typical and atypical lung carcinoids.
Pusceddu S; Lo Russo G; Macerelli M; Proto C; Vitali M; Signorelli D; Ganzinelli M; Scanagatta P; Duranti L; Trama A; Buzzoni R; Pelosi G; Pastorino U; de Braud F; Garassino MC
Crit Rev Oncol Hematol; 2016 Apr; 100():167-76. PubMed ID: 26917456
[TBL] [Abstract][Full Text] [Related]
8. Advances in neuroendocrine lung tumors.
Travis WD
Ann Oncol; 2010 Oct; 21 Suppl 7():vii65-71. PubMed ID: 20943645
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids.
Caplin ME; Baudin E; Ferolla P; Filosso P; Garcia-Yuste M; Lim E; Oberg K; Pelosi G; Perren A; Rossi RE; Travis WD;
Ann Oncol; 2015 Aug; 26(8):1604-20. PubMed ID: 25646366
[TBL] [Abstract][Full Text] [Related]
10. [Diagnosis and treatment of the neuroendocrine tumors of the lung].
Gálffy G
Magy Onkol; 2018 Jul; 62(2):113-118. PubMed ID: 30027939
[TBL] [Abstract][Full Text] [Related]
11. Orthopedia homeobox is preferentially expressed in typical carcinoids of the lung.
Hanley KZ; Dureau ZJ; Cohen C; Shin DM; Owonikoko TK; Sica GL
Cancer Cytopathol; 2018 Apr; 126(4):236-242. PubMed ID: 29316326
[TBL] [Abstract][Full Text] [Related]
12. Survival analysis of 200 pulmonary neuroendocrine tumors with clarification of criteria for atypical carcinoid and its separation from typical carcinoid.
Travis WD; Rush W; Flieder DB; Falk R; Fleming MV; Gal AA; Koss MN
Am J Surg Pathol; 1998 Aug; 22(8):934-44. PubMed ID: 9706973
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary Neuroendocrine Tumors.
Borczuk AC
Surg Pathol Clin; 2020 Mar; 13(1):35-55. PubMed ID: 32005434
[TBL] [Abstract][Full Text] [Related]
14. The Role of Histologic Grading and Ki-67 Index in Predicting Outcomes in Pulmonary Carcinoid Tumors.
Dermawan JKT; Farver CF
Am J Surg Pathol; 2020 Feb; 44(2):224-231. PubMed ID: 31490236
[TBL] [Abstract][Full Text] [Related]
15. Lung carcinoid tumours: histology and Ki-67, the eternal rivalry.
Centonze G; Maisonneuve P; Simbolo M; Lagano V; Grillo F; Fabbri A; Prinzi N; Garzone G; Filugelli M; Pardo C; Mietta A; Pusceddu S; Sabella G; Bercich L; Mangogna A; Rolli L; Grisanti S; Benvenuti MR; Pastorino U; Roz L; Scarpa A; Berruti A; Capella C; Milione M
Histopathology; 2023 Jan; 82(2):324-339. PubMed ID: 36239545
[TBL] [Abstract][Full Text] [Related]
16. Incidence and Prognostic Significance of Carcinoid Lymph Node Metastases.
Kneuertz PJ; Kamel MK; Stiles BM; Lee BE; Rahouma M; Harrison SW; Altorki NK; Port JL
Ann Thorac Surg; 2018 Oct; 106(4):981-988. PubMed ID: 29908980
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of diagnostic and prognostic significance of Ki-67 index in pulmonary carcinoid tumours.
Clay V; Papaxoinis G; Sanderson B; Valle JW; Howell M; Lamarca A; Krysiak P; Bishop P; Nonaka D; Mansoor W
Clin Transl Oncol; 2017 May; 19(5):579-586. PubMed ID: 27848218
[TBL] [Abstract][Full Text] [Related]
18. Neuroendocrine tumors of the lung: clinicopathological and molecular features.
Iyoda A; Azuma Y; Sano A
Surg Today; 2020 Dec; 50(12):1578-1584. PubMed ID: 32193632
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of 252 patients with bronchopulmonary neuroendocrine tumours treated at the Copenhagen NET Centre of Excellence.
Grøndahl V; Binderup T; Langer SW; Petersen RH; Nielsen K; Kjaer A; Federspiel B; Knigge U
Lung Cancer; 2019 Jun; 132():141-149. PubMed ID: 31097087
[TBL] [Abstract][Full Text] [Related]
20. ERCC1 and Ki67 in small cell lung carcinoma and other neuroendocrine tumors of the lung: distribution and impact on survival.
Skov BG; Holm B; Erreboe A; Skov T; Mellemgaard A
J Thorac Oncol; 2010 Apr; 5(4):453-9. PubMed ID: 20104194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]